May 31, 2007 08:40 ET

Stock Market Watch for Thursday, May 31, 2007: LDPH, Received Final Approval Shares Will Be Available for Trading Through the Frankfurt Stock Exchange (FWB)

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Peter Antipatis of Capital Research Group Inc.

MIAMI, FL--(Marketwire - May 31, 2007) - Names the following stocks to its Stock Alerts List: London & Pacific Healthcare, Inc. (PINKSHEETS: LDPH), Valence Technology, Inc. (NASDAQ: VLNC), Novacea, Inc. (NASDAQ: NOVC), Coldwater Creek Inc. (NASDAQ: CWTR).

London & Pacific Healthcare, Inc. (PINKSHEETS: LDPH) ("London & Pacific," the "Company") is pleased to announce that it has received final approval from Deutsche Boerse AG and its shares will be available for trading through the Frankfurt Stock Exchange (FWB), the third largest exchange in the world. The FWB is an international trading center and is reflected by its member structure in which approximately 140 of its more than 300 market participants come from abroad.

Listing on the exchange enables London & Pacific to communicate its value and growth to the international investment community and gain access to global capital markets. The Company is trading under the symbol "EGU."

"Our business model is applicable around the world. European investors have shown an interest in London & Pacific due to our strong business plan and near-term revenue growth profile. The listing on the Frankfurt Exchange marks an important milestone in our corporate strategy to create shareholder value and increase exposure," said Executive Chairman, Stuart Bruck. "The new FWB listing not only facilitates investment in the Company by European investors, but also creates further liquidity and increased awareness of London & Pacific."

London & Pacific Healthcare, Inc., with offices in Los Angeles and London, operates three synergistic operating divisions that capitalize on emerging growth opportunities in the global healthcare industry. Its London-based division City & Westminster Advisers Limited provides comprehensive strategic and financial advisory services to healthcare start-ups, small and mid-sized organizations. Its two California-based divisions, HealthSPAC LLC, acts as an incubator for Special Purpose Acquisition Companies (SPACs), and Healthcare Fund Advisors LLC, provides specialized buy-side sourcing and analysis services to clients that invest in the global healthcare sector. For additional information, please visit the corporate website at

Other stocks highlighted include Valence Technology, Inc. (NASDAQ: VLNC): Hot Stocks List, up 28% on 3.4 million shares, Novacea, Inc. (NASDAQ: NOVC): Hot Stocks List, up 86% on 21 million shares, Coldwater Creek Inc. (NASDAQ: CWTR): Hot Stocks List, up 16% on 15 million shares.'s Daily Stock Updates:, a leader in corporate communications and finance, highlights stocks that are in the news, have traded high volume, or experienced a large change in price in recent sessions. The aforementioned commentary is not meant to be indicative of a "long term" view of any of the companies listed. For more go to Daily Ranking is consistently ranked in the top 4 on the "Best performing promoters of all time" list. This is out of over 1,000 promoters and promotional campaigns tracked by Visit for more details.

All material herein was prepared by CRG Partners, Inc. (CRGP) based upon information believed to be reliable. The information contained herein is not guaranteed by CRGP to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. CRGP is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. CRGP has been compensated by third party shareholders with shares or with cash from the company on behalf of one or more of the companies mentioned in this opinion. CRGP has been compensated one hundred fifty thousand shares for LDPH. CRGP has also purchased twenty thousand shares in the open market. CRGP intends to sell its shares. CRGP has sold approximately zero LDPH shares to date. CRGP may sell its shares for less than the target price given in this opinion. In addition to any compensation mentioned above, additional compensation can be equal to ten percent of any newly issued or registered securities of the profiled companies. CRGP and its web site are operated under a license from Capital Research Group, Inc., Inc. and One Source Solutions Inc. (Licensors) and CRGP is not the agent of any of the Licensors and CRGP is solely responsible for all statements made herein. CRGP's affiliates, officers, directors and employees intend to buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. CRGP will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

Contact Information